GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Parp1 | decreases activity | ISO | PARP1 (Homo sapiens) | 6480464 | CTD | linsidomine results in decreased activity of PARP1 protein | PMID:31152818 | Parp1 | decreases expression | ISO | Parp1 (Mus musculus) | 6480464 | CTD | linsidomine results in decreased expression of PARP1 protein | PMID:12880480 | Parp1 | decreases folding | ISO | PARP1 (Homo sapiens) | 6480464 | CTD | linsidomine results in decreased folding of PARP1 protein | PMID:31152818 | Parp1 | increases cleavage | ISO | PARP1 (Homo sapiens) | 6480464 | CTD | linsidomine results in increased cleavage of PARP1 protein | PMID:34519134 | Parp1 | multiple interactions | ISO | PARP1 (Homo sapiens) | 6480464 | CTD | [bosutinib co-treated with linsidomine] affects the expression of PARP1 protein; bosutinib affects the reaction [linsidomine results in increased cleavage of PARP1 protein]; linsidomine inhibits the reaction [PARP1 protein binds to Zinc]; linsidomine results in decreased activity of and results in increased nitrosation of PARP1 protein | PMID:31152818 PMID:34519134 | Parp1 | multiple interactions | ISO | Parp1 (Mus musculus) | 6480464 | CTD | Selegiline inhibits the reaction [linsidomine results in decreased expression of PARP1 protein] | PMID:12880480 | |
Go Back to source page | Continue to Ontology report |